Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats
VolitionRx expanded its supply agreement with Fujifilm Vet Systems in Japan to cover the Nu.Q® Vet Feline Test, extending the Nu.Q® technology to Japan's nearly nine million cats. The company expects the feline test to be the world's first simple, affordable blood-based liquid biopsy for feline cancer, with development to run on the IDS i10 automated analyzer platform.
Key figures
- Japan cat population
- almost nine million
- Japan vet facilities
- 11000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.